Martynoga B, Mateo JL, Zhou B, Andersen J, Achimastou A, Urban N, et al
Glutathione S-transferases: an overview in cancer research
BPC-157 is typically administered as an injectable peptide solution
Metabolic Health Neutral on glucose control: Unlike HGH, AOD-9604 does not negatively impact insulin sensitivity or fasting blood glucose
In therapy, synthetic or bioidentical peptides are introduced, usually by injection but sometimes through capsules, creams, or nasal sprays, to mimic or enhance these natural signals
The 250500 mcg subcutaneous range used in current research contexts sits below the 1 mg clinical trial dose, partly because subcutaneous bioavailability differs from the oral administration used in some trial arms